Document is current
Any future updates will be listed below
-
Authors
Gonzalez-Bocco, Isabel H. https://orcid.org/0000-0002-2073-092X
Beluch, Katherine
Cho, Alyssa
Lahoud, Chloe
Reyes, Fabiola A.
Moshovitis, Dimitrios G.
Unger-Mochrie, Gillian M.
Wang, Wei
Hammond, Sarah P.
Manne-Goehler, Jennifer
Koo, Sophia
-
Funding
Funding for this research was provided by:
GlaxoSmithKline
Vir Biotechnology
- License Information
-
More Information
Article History
Received: 4 July 2022
Accepted: 26 May 2023
First Online: 16 June 2023
Declarations
:
: The Dana Farber Cancer Institute Institutional Review Board approved this protocol on January 26, 2022.
: Not applicable.
: Dr. Laurie Glimcher, the President/CEO of Dana-Farber Cancer Institute, is a paid member of the board of directors of GSK, the company that is providing financial support and investigational product for the conduct of this study. Dr. Glimcher is not a member of the study team or otherwise participating in this trial.
